newsfilter
← Latest News
GlobeNewswire·

Axovant Announces Financial Results for Third Fiscal Quarter and Nine Months Ended December 31, 2019

NEW YORK and BASEL, Switzerland, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today provided financial...